Your browser doesn't support javascript.
loading
piR-823 demonstrates tumor oncogenic activity in esophageal squamous cell carcinoma through DNA methylation induction via DNA methyltransferase 3B.
Su, Jing-Fen; Zhao, Fang; Gao, Zhao-Wei; Hou, Yong-Jie; Li, Yuan-Yuan; Duan, Li-Juan; Lun, Shu-Min; Yang, Hai-Jun; Li, Jun-Kuo; Dai, Ning-Tao; Shen, Fang-Fang; Zhou, Fu-You.
Afiliação
  • Su JF; Anyang Key Laboratory for Esophageal Cancer Research, Anyang Cancer Hospital, the Forth Affiliated Hospital of Henan University of Science and Technology, Anyang, Henan, People's Republic of China.
  • Zhao F; Anyang Key Laboratory for Esophageal Cancer Research, Anyang Cancer Hospital, the Forth Affiliated Hospital of Henan University of Science and Technology, Anyang, Henan, People's Republic of China.
  • Gao ZW; Anyang Key Laboratory for Esophageal Cancer Research, Anyang Cancer Hospital, the Forth Affiliated Hospital of Henan University of Science and Technology, Anyang, Henan, People's Republic of China.
  • Hou YJ; Anyang Key Laboratory for Esophageal Cancer Research, Anyang Cancer Hospital, the Forth Affiliated Hospital of Henan University of Science and Technology, Anyang, Henan, People's Republic of China.
  • Li YY; Biotecan company, Shanghai, People's Republic of China.
  • Duan LJ; Anyang Key Laboratory for Esophageal Cancer Research, Anyang Cancer Hospital, the Forth Affiliated Hospital of Henan University of Science and Technology, Anyang, Henan, People's Republic of China.
  • Lun SM; Anyang Key Laboratory for Esophageal Cancer Research, Anyang Cancer Hospital, the Forth Affiliated Hospital of Henan University of Science and Technology, Anyang, Henan, People's Republic of China.
  • Yang HJ; Anyang Key Laboratory for Esophageal Cancer Research, Anyang Cancer Hospital, the Forth Affiliated Hospital of Henan University of Science and Technology, Anyang, Henan, People's Republic of China.
  • Li JK; Anyang Key Laboratory for Esophageal Cancer Research, Anyang Cancer Hospital, the Forth Affiliated Hospital of Henan University of Science and Technology, Anyang, Henan, People's Republic of China.
  • Dai NT; Anyang Key Laboratory for Esophageal Cancer Research, Anyang Cancer Hospital, the Forth Affiliated Hospital of Henan University of Science and Technology, Anyang, Henan, People's Republic of China.
  • Shen FF; Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital, Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
  • Zhou FY; Anyang Key Laboratory for Esophageal Cancer Research, Anyang Cancer Hospital, the Forth Affiliated Hospital of Henan University of Science and Technology, Anyang, Henan, People's Republic of China. Electronic address: ayzhoufuyou@163.com.
Pathol Res Pract ; 216(4): 152848, 2020 Apr.
Article em En | MEDLINE | ID: mdl-32051106
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / RNA Interferente Pequeno / DNA (Citosina-5-)-Metiltransferases / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Pathol Res Pract Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / RNA Interferente Pequeno / DNA (Citosina-5-)-Metiltransferases / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Pathol Res Pract Ano de publicação: 2020 Tipo de documento: Article